Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1960 1
1964 5
1968 4
1969 1
1971 2
1973 1
1974 1
1976 1
1978 1
1980 1
1981 1
1982 2
1983 2
1985 1
1986 2
1988 1
1989 7
1990 2
1991 5
1992 5
1993 3
1994 5
1995 4
1996 3
1997 4
1999 7
2000 8
2001 12
2002 7
2003 6
2004 8
2005 5
2006 12
2007 6
2008 4
2009 3
2010 12
2011 14
2012 13
2013 17
2014 17
2015 16
2016 14
2017 13
2018 9
2019 6
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 10512237

253 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging.
Adachi M, Hosoya T, Haku T, Yamaguchi K, Kawanami T. Adachi M, et al. AJNR Am J Neuroradiol. 1999 Sep;20(8):1500-6. AJNR Am J Neuroradiol. 1999. PMID: 10512237 Free article.
Topographical alterations of the midbrain and the substantia nigra following unilateral posteroventral pallidotomy in patients with Parkinson's disease using routine and multishot diffusion-weighted magnetic resonance imaging.
Adachi M, Kurimura M, Saito S, Hosoya T, Kayama T, Kato T. Adachi M, et al. Neuroradiology. 2002 Jul;44(7):579-85. doi: 10.1007/s00234-002-0744-8. Epub 2002 Jun 19. Neuroradiology. 2002. PMID: 12136359
[MRI in Parkinson's disease and vascular parkinsonism--study on the lesion of substantia nigra].
Aotsuka A, Shinotoh H, Hirayama K, Ikehira H, Fukuda H. Aotsuka A, et al. Rinsho Shinkeigaku. 1991 Jun;31(6):619-24. Rinsho Shinkeigaku. 1991. PMID: 1934776 Japanese.
T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP. Schwarz ST, et al. Mov Disord. 2011 Aug 1;26(9):1633-8. doi: 10.1002/mds.23722. Epub 2011 Apr 12. Mov Disord. 2011. PMID: 21491489
Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging.
Minati L, Grisoli M, Carella F, De Simone T, Bruzzone MG, Savoiardo M. Minati L, et al. AJNR Am J Neuroradiol. 2007 Feb;28(2):309-13. AJNR Am J Neuroradiol. 2007. PMID: 17297002 Free article. Clinical Trial.
Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism.
Brar S, Henderson D, Schenck J, Zimmerman EA. Brar S, et al. Arch Neurol. 2009 Mar;66(3):371-4. doi: 10.1001/archneurol.2008.586. Arch Neurol. 2009. PMID: 19273756
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U. Péran P, et al. Brain. 2010 Nov;133(11):3423-33. doi: 10.1093/brain/awq212. Epub 2010 Aug 23. Brain. 2010. PMID: 20736190
[Magnetic resonance imaging in Parkinson's disease--the evaluation of the width of pars compacta on T2 weighted image].
Moriwaka F, Tashiro K, Itoh K, Hamada T, Miyasaka K. Moriwaka F, et al. Rinsho Shinkeigaku. 1992 Jan;32(1):8-12. Rinsho Shinkeigaku. 1992. PMID: 1628441 Japanese.
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A. Sasaki M, et al. Neuroreport. 2006 Jul 31;17(11):1215-8. doi: 10.1097/01.wnr.0000227984.84927.a7. Neuroreport. 2006. PMID: 16837857
Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N. Mascalchi M, et al. Radiol Med. 2005 Mar;109(3):155-97. Radiol Med. 2005. PMID: 15775887 Review. English, Italian.
253 results
Jump to page
Feedback